Open Access. Powered by Scholars. Published by Universities.®

Public Relations and Advertising Commons

Open Access. Powered by Scholars. Published by Universities.®

College of Journalism and Mass Communications: Faculty Publications

2023

Articles 1 - 2 of 2

Full-Text Articles in Public Relations and Advertising

Prevalence And Factors Associated With Vaping Cannabidiol Among Us Adolescents, Hongying Daisy Dai, Roma Subramanian, Avina Mahroke, Ming Wang Aug 2023

Prevalence And Factors Associated With Vaping Cannabidiol Among Us Adolescents, Hongying Daisy Dai, Roma Subramanian, Avina Mahroke, Ming Wang

College of Journalism and Mass Communications: Faculty Publications

IMPORTANCE e-Cigarette use and vaping marijuana (cannabis) are popular among US adolescents. Cannabidiol (CBD) is a compound found in the cannabis plant that has recently increased in use.

OBJECTIVES To examine the prevalence of and factors associated with youths vaping CBD

DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study included a nationally representative sample of students from middle and high schools (typical age, 11-18 years) in the US from the 2022 National Youth Tobacco Survey, conducted from January to May 2022.

EXPOSURE Demographic characteristics, harm perception of tobacco use, and vaping behaviors.

MAIN OUTCOMES AND MEASURES The main outcomes were weighted …


Thyroid Sat510 I-131 Therapy With Dosimetry For Advanced Thyroid Carcinoma: Recombinant Tsh Vs Thyroid Hormone Withdrawal, Dana Awad, Jarod Hamsa, Abbey Fingeret, Craig M. Johnson, Frank Rutar, Carrie Carso, Anupam Kotwal, Anery Patel, Angela Thornburg, Whitney Sears Goldner Jun 2023

Thyroid Sat510 I-131 Therapy With Dosimetry For Advanced Thyroid Carcinoma: Recombinant Tsh Vs Thyroid Hormone Withdrawal, Dana Awad, Jarod Hamsa, Abbey Fingeret, Craig M. Johnson, Frank Rutar, Carrie Carso, Anupam Kotwal, Anery Patel, Angela Thornburg, Whitney Sears Goldner

College of Journalism and Mass Communications: Faculty Publications

Background: Dosimetry can be used to calculate an optimal and safe dose of Iodine-131 (I-131) for treatment of advanced differentiated thyroid cancer (DTC). Thyroid hormone withdrawal (THW) is the preferred method of TSH elevation for I-131 therapy with dosimetry. At our institution, Recombinant TSH (RhTSH) is used in patients in whom prolonged hypothyroidism is deemed clinically unsafe or cannot tolerate THW. We aim to evaluate if RhTSH and THW are equivalent methods of preparation for I-131 therapy using dosimetry (I-131D).